Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine

Zheng Quan Toh, Beth Temple, Tran Ngoc Huu, Vo Thi Trang Dai, Nguyen Trong Toan, Doan Y. Uyen, Kathryn Bright, Lien Anh Ha Do, E. Kim Mulholland, Paul V. Licciardi

Research output: Contribution to journalArticle

Abstract

This brief communication describes the findings from a randomised controlled trial in Vietnam that co-administration of measles vaccine (MV) with 10-valent pneumococcal conjugate vaccine (PCV10, Synflorix®, GSK) does not affect the immunogenicity of MV. These findings are most relevant for low- and middle-income countries (LMICs) in Asia considering PCV introduction.

Original languageEnglish
Article number76
Pages (from-to)1-3
Number of pages3
Journalnpj Vaccines
Volume5
Issue number1
DOIs
Publication statusPublished - 1 Dec 2020
Externally publishedYes

Fingerprint Dive into the research topics of 'Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine'. Together they form a unique fingerprint.

  • Cite this

    Toh, Z. Q., Temple, B., Huu, T. N., Dai, V. T. T., Toan, N. T., Uyen, D. Y., Bright, K., Do, L. A. H., Mulholland, E. K., & Licciardi, P. V. (2020). Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine. npj Vaccines, 5(1), 1-3. [76]. https://doi.org/10.1038/s41541-020-00225-z